Trials / Completed
CompletedNCT03063749
RESOLUTE ONYX Post-Approval Study
A Post-approval Study of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 416 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System | Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 2.0 mm - 4.0 mm |
| DEVICE | Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System | Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 4.5 mm - 5.0 mm |
Timeline
- Start date
- 2017-03-30
- Primary completion
- 2018-10-20
- Completion
- 2022-08-18
- First posted
- 2017-02-24
- Last updated
- 2023-11-22
Locations
28 sites across 4 countries: United States, Belgium, France, Slovakia
Source: ClinicalTrials.gov record NCT03063749. Inclusion in this directory is not an endorsement.